Enhancing Telemedicine for T2D

Description

The goal of this pilot clinical trial is to assess feasibility of an intervention to deliver comprehensive, high-quality diabetes care through telemedicine among adults with type 2 diabetes who use insulin and have multiple chronic health conditions. The main question it aims to answer is: Is an enhanced telemedicine intervention for type 2 diabetes compared to usual telemedicine care feasible? Researchers will compare the enhanced telemedicine intervention to usual telemedicine care to see if there are differences in patient satisfaction or preliminary clinical outcomes. Participants will complete 2-3 telemedicine diabetes care visits over approximately 6 months, as well as complete survey measures with each diabetes care visit. Patients in the intervention group will also receive additional support, including pre-visit preparation phone calls, diabetes self-management education and support aligned with their visits, and post-visit follow-up calls.

Conditions

Type 2 Diabetes

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this pilot clinical trial is to assess feasibility of an intervention to deliver comprehensive, high-quality diabetes care through telemedicine among adults with type 2 diabetes who use insulin and have multiple chronic health conditions. The main question it aims to answer is: Is an enhanced telemedicine intervention for type 2 diabetes compared to usual telemedicine care feasible? Researchers will compare the enhanced telemedicine intervention to usual telemedicine care to see if there are differences in patient satisfaction or preliminary clinical outcomes. Participants will complete 2-3 telemedicine diabetes care visits over approximately 6 months, as well as complete survey measures with each diabetes care visit. Patients in the intervention group will also receive additional support, including pre-visit preparation phone calls, diabetes self-management education and support aligned with their visits, and post-visit follow-up calls.

Pilot Study Enhancing Telemedicine Care Delivery for Adults With Complex Type 2 Diabetes

Enhancing Telemedicine for T2D

Condition
Type 2 Diabetes
Intervention / Treatment

-

Contacts and Locations

Pittsburgh

University of Pittsburgh, Pittsburgh, Pennsylvania, United States, 15213

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * adults 18 years or older
  • * Diagnosis of type 2 diabetes based on abbreviated ICD-10 code E11.X in medical record or self-report
  • * HbA1c greater than or equal to 8% based on most recent value at time of recruitment
  • * Patients must own or have access to a smart phone, tablet, or home computer with data or internet connection that allows access to video-based visits
  • * Patient must use insulin
  • * Patients must have \>2 comorbid chronic health conditions
  • * Be able to provide informed consent
  • * Age over 80 based on date of birth in electronic medical record
  • * Visit with an endocrinologist in the prior 3 years
  • * Dementia, ESRD, malignancy based on abbreviated ICD-10 codes below in medical record or self-report of associated condition
  • * Dementia: A81.0x, F01.5x, F02.8x, F03.9x, F10.27, F10.97, F13.27, F13.97, F18.97, F19.17, F19.27, F19.97, G30.x, G31.0x, G31.1, G31.83, G31.85
  • * Malignancy, except non-melanoma skin cancer: C00.x-C14.x, C15.x-C26.x, C3x.xx, C40.xx-C41.x, C43.x, C4A.xx, C45.x-C49.xx, C50.xxx, C51.x-C58, C60.x-C63.x, C64.x- C68.x, C69.xx-C72.x, C73-C76.x, C7A.xx, C80.xx-C96.x (except C90.x1, C91.x1, C92.x1, C93.x1, C94.x1, C95.x1)
  • * ESRD N18.6
  • * Type 1, gestational, or other diabetes based on abbreviated ICD-10 codes below in medical record or self-report of associated condition
  • * Type 1 diabetes: E10.X
  • * Gestational diabetes: O24.X, E08.X
  • * Other diabetes: E09.X, E13.2
  • * Pregnant or planning to become pregnant in next 6 months
  • * Currently enrolled in another diabetes management intervention study

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Pittsburgh,

Margaret Zupa, MDMS, PRINCIPAL_INVESTIGATOR, University of Pittsburgh

Study Record Dates

2026-07-30